Autopsy report · NCT01727206
Pilot Study of Tocilizumab in Patients With Erdheim-Chester Disease
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 1 month before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Ospedale San Raffaele
- Sponsor type
- University, hospital or other
- Conditions
- Erdheim-Chester Disease
- Interventions
- Tocilizumab
- Participants
- 3
- Sites
- 1
- Countries
- Italy
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.